Conjugate nanoparticle platform development for HIV-1 envelope immunogens — KEVIN O SAUNDERS (DUKE UNIVERSITY)
ABSTRACT – OVERALL HIV-1 broadly neutralizing antibodies (bnAbs) are protective in animal models of HIV-1 infection, but are not elicited in humans by current vaccine regimens. To elicit bnAbs, the B
| Project title | Conjugate nanoparticle platform development for HIV-1 envelope immunogens |
|---|---|
| Project number | 1U19AI160546-01A1 |
| PI name | KEVIN O SAUNDERS |
| Institution | DUKE UNIVERSITY |
| Funding mechanism | U19 |
| Agency | NIAID |
| Award amount | $4.72M |
| Fiscal year | 2022 |
| Project start | 2021-12-17T00:00:00 |
| Project end | 2026-11-30T00:00:00 |
| Abstract | ABSTRACT – OVERALL HIV-1 broadly neutralizing antibodies (bnAbs) are protective in animal models of HIV-1 infection, but are not elicited in humans by current vaccine regimens. To elicit bnAbs, the B |
| Key terms | <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><AICDA><AICDA protein><AID gene><AID pro |
$799/mo
Try GrantRadar →